Cytek® Biosciences Named “Overall BioTech Company of the Year” in 2024 BioTech Breakthrough Awards Program
BioTech Company of the Year Cytek Biosciences has been named “Overall BioTech Company of the Year” in the fourth annual…
Pharmaceuticals, Biotechnology and Life Sciences
BioTech Company of the Year Cytek Biosciences has been named “Overall BioTech Company of the Year” in the fourth annual…
Improved operating performance by reducing net loss by $52.5 million; reported net loss of $4.3 million and $56.8 million for…
Abivax Establishes an At-the-Market (ATM) Program on Nasdaq PARIS, France, November 19, 2024 – 10:30PM CET – Abivax SA (Euronext…
Conduit Pharmaceuticals strengthens its Board of Directors with the addition of Simon Fry, a seasoned investment banking executive with over…
REDWOOD CITY, Calif., Nov. 19, 2024 (GLOBE NEWSWIRE) — Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for efficient…
Targeting Transformative Solutions for Aplastic Anemia and Beyond SAN DIEGO, Nov. 19, 2024 (GLOBE NEWSWIRE) — Regen BioPharma, Inc. (OTC…
NEW YORK, Nov. 19, 2024 (GLOBE NEWSWIRE) — Psyence Biomedical Ltd. (Nasdaq: PBM) (“Psyence Biomed” or the “Company”) today announced…
MALVERN, Pa., Nov. 19, 2024 (GLOBE NEWSWIRE) — TELA Bio, Inc. (NASDAQ: TELA), a commercial-stage medical technology company focused on…
SOUTH SAN FRANCISCO, Calif., Nov. 19, 2024 (GLOBE NEWSWIRE) — Aligos Therapeutics, Inc. (Nasdaq: ALGS, “Aligos”), a clinical stage biopharmaceutical…
DENVER, Nov. 19, 2024 (GLOBE NEWSWIRE) — The 13th annual MJBizCon, the largest, most established cannabis business conference and expo in the…